Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | monoglyceride lipase | Starlite/ChEMBL | References |
Homo sapiens | fatty acid amide hydrolase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | fatty acid amide hydrolase | 579 aa | 471 aa | 26.5 % |
Plasmodium falciparum | esterase, putative | monoglyceride lipase | 303 aa | 254 aa | 19.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.1031 | 0.1205 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 0.0049 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.7939 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0084 | 0 | 0.5 |
Brugia malayi | amidase | 0.0123 | 0.0049 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.0049 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.7939 | 1 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.7939 | 1 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 0.0049 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.7939 | 1 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0084 | 0 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0123 | 0.0049 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.7939 | 1 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0084 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.1031 | 0.1205 | 1 |
Schistosoma mansoni | amidase | 0.0123 | 0.0049 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0084 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.7939 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.1031 | 0.1205 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 0.0049 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 0.0049 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.1031 | 0.1205 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.7939 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.1031 | 0.1205 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.18 | Inhibition of human recombinant MAGL expressed in HEK293 cells using 2-AG as substrate | ChEMBL. | 25282655 |
IC50 (binding) | = 7.76 | Inhibition of human recombinant FAAH expressed in COS7 cells using anandamide as substrate | ChEMBL. | 25282655 |
IC50 (binding) | = 3.4 nM | Inhibition of human recombinant FAAH expressed in COS7 cells using anandamide as substrate | ChEMBL. | 25282655 |
IC50 (binding) | = 660 nM | Inhibition of human recombinant MAGL expressed in HEK293 cells using 2-AG as substrate | ChEMBL. | 25282655 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.